|
|
Article: New England Journal of Medicine Reports That Stool-Based DNA Test is Four-Times More Sensitive Than Fecal Occult Blood Test for Colorectal Cancer Screening.
- Article from:
- Business Wire
- Article date:
- December 22, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MARLBOROUGH, Mass. -- EXACT Sciences' colorectal cancer screening test - PreGen-Plus(TM) -- provides a more sensitive, non-invasive screening option for average risk 50-year-old+ Americans
EXACT Sciences Corporation (NASDAQ:EXAS) today announced that the New England Journal of Medicine has published the results of the Company's multi-center study, the first-ever study of its stool-based DNA test, PreGen-Plus, versus the most widely used fecal occult blood test, Hemoccult(R) II. Researchers found that the Company's non-invasive stool-based DNA test for colorectal cancer was four-times more sensitive than the fecal occult blood test (FOBT), the only other entirely ...